文献速递肿瘤 PET/CT

非小细胞肺癌动态18F-氟米索硝唑PET数据的药代动力学分析

Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.
PubMed 文献 · J Nucl Med · 2017-02-23

研究对16例III-IV期非小细胞肺癌患者在放疗前行动态18F-FMISO PET扫描,采用两组织三室不可逆模型进行药代动力学分析,首次报道注射后延长至3小时的动态数据。结果显示所有病灶均有明显的18F-FMISO摄取,病灶捕获速率平均为正常肺的1.6倍、肌肉的4.4倍,除3例外所有病灶均显示一定程度的乏氧。

要点

  • 16例III-IV期非小细胞肺癌患者放疗前行18F-FDG静态和18F-FMISO动态PET/CT扫描,动态扫描持续168±15分钟。
  • 病灶捕获速率k3平均为正常肺的1.6倍、肌肉的4.4倍,几乎所有组织类型中k3与Ki呈显著强相关。
  • 除3例外所有病灶基于非零k3值显示一定程度的乏氧,各病灶间18F-FMISO递送(K1值)存在差异。

核心结论

  • 所有病灶均显示明显的18F-FMISO摄取,各病灶间18F-FMISO递送存在差异,表现为动力学速率常数K1值的变化。
  • 除3例外,基于非零k3值,所有病灶均显示一定程度的乏氧。

研究设计与样本

  • 16例确诊非小细胞肺癌患者,放疗前接受2次PET/CT扫描(间隔1-3天):一次3分钟静态18F-FDG和一次持续168±15分钟的18F-FMISO动态扫描。
  • 动态数据分3个连续PET/CT动态采集时段获取,彼此配准后用药物动力学建模软件分析。
  • 采用两组织三室不可逆模型进行药代动力学分析,基于配准的18F-FDG图像确定感兴趣区,对每例患者病灶、正常肺和肌肉的感兴趣区平均及体素级时间-活性曲线估算动力学参数。

主要发现

  • 得出了非小细胞肺癌病灶以及正常肺和肌肉的18F-FMISO动力学参数平均值。
  • 病灶捕获速率平均为正常肺的1.6倍、肌肉的4.4倍。
  • 几乎所有病例中,所有组织类型的k3与Ki均呈显著强相关。
  • TBR与k3的相关性较不明确,仅41%的病灶显示中至强相关。
  • 肿瘤体素级K1-k3相关性多变,但76%的病灶为负相关,整体呈弱负相关(平均R=-0.23±0.39);两种正常组织在超过60%的患者中呈显著正相关,其中41%具有中至强相关(R>0.5)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hypoxic tumors exhibit increased resistance to radiation, chemical, and immune therapies. 18F-fluoromisonidazole (18F-FMISO) PET is a noninvasive, quantitative imaging technique used to evaluate the magnitude and spatial distribution of tumor hypoxia. In this study, pharmacokinetic analysis (PKA) of 18F-FMISO dynamic PET extended to 3 h after injection is reported for the first time, to our knowledge, in stage III-IV non-small cell lung cancer (NSCLC) patients. Methods: Sixteen patients diagnosed with NSCLC underwent 2 PET/CT scans (1-3 d apart) before radiation therapy: a 3-min static 18 F-FDG and a dynamic 18F-FMISO scan lasting 168 ± 15 min. The latter data were acquired in 3 serial PET/CT dynamic imaging sessions, registered with each other and analyzed using pharmacokinetic modeling software. PKA was performed using a 2-tissue, 3-compartment irreversible model, and kinetic parameters were estimated for the volumes of interest determined using coregistered 18F-FDG images for both the volume of interest-averaged and the voxelwise time-activity curves for each patient's lesions, normal lung, and muscle. Results: We derived average values of 18F-FMISO kinetic parameters for NSCLC lesions as well as for normal lung and muscle. We also investigated the correlation between the trapping rate (k3) and delivery rate (K1), influx rate (Ki ) constants, and tissue-to-blood activity concentration ratios (TBRs) for all tissues. Lesions had trapping rates 1.6 times larger, on average, than those of normal lung and 4.4 times larger than those in muscle. Additionally, for almost all cases, k3 and Ki had a significant strong correlation for all tissue types. The TBR-k3 correlation was less straightforward, showing a moderate to strong correlation for only 41% of lesions. Finally, K1-k3 voxelwise correlations for tumors were varied, but negative for 76% of lesions, globally exhibiting a weak inverse relationship (average R = -0.23 ± 0.39). However, both normal tissue types exhibited significant positive correlations for more than 60% of patients, with 41% having moderate to strong correlations (R > 0.5). Conclusion: All lesions showed distinct 18F-FMISO uptake. Variable 18F-FMISO delivery was observed across lesions, as indicated by the variable values of the kinetic rate constant K1 Except for 3 cases, some degree of hypoxia was apparent in all lesions based on their nonzero k3 values.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Schwartz J, Grkovski M, Rimner A, et al. Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer. J Nucl Med. 2017. PMID: 28232611. doi:10.2967/jnumed.116.180422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。